The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Berkle Sheldon since 2006.
The trader's CIK number is 1350078.
At the time of the last reporting, Berkle Sheldon was the President and CEO of Altus Pharmaceuticals Inc.. (stock ticker symbol ALTU).
Also see all insider trading activities at Altus Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | ALTU | 0 | $0 | 61,750 | $918,611 | 93,750 | $367,500 |
| 2006 | ALTU | 0 | $0 | 26,000 | $461,369 | 34,000 | $133,280 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-12-13 | ALTU | Option Ex | 32,000 | 3.92 | 125,440 |
| 2007-08-01 | ALTU | Sale | 3,250 | 9.89 | 32,142 |
| 2007-08-01 | ALTU | Option Ex | 3,250 | 3.92 | 12,740 |
| 2007-07-19 | ALTU | Sale | 8,000 | 11.54 | 92,320 |
| 2007-07-18 | ALTU | Sale | 11,500 | 11.54 | 132,710 |
| 2007-07-19 | ALTU | Option Ex | 8,000 | 3.92 | 31,360 |
| 2007-07-18 | ALTU | Option Ex | 11,500 | 3.92 | 45,080 |
| 2007-04-02 | ALTU | Sale | 9,750 | 15.03 | 146,542 |
| 2007-04-02 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-03-01 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-03-01 | ALTU | Sale | 9,750 | 15.68 | 152,880 |
| 2007-02-01 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-02-01 | ALTU | Sale | 9,750 | 18.25 | 177,937 |
| 2007-01-03 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2007-01-03 | ALTU | Sale | 9,750 | 18.88 | 184,080 |
| 2006-12-22 | ALTU | Option Ex | 8,000 | 3.92 | 31,360 |
| 2006-12-20 | ALTU | Sale | 6,500 | 20.07 | 130,455 |
| 2006-12-20 | ALTU | Option Ex | 6,500 | 3.92 | 25,480 |
| 2006-12-01 | ALTU | Sale | 9,750 | 17.87 | 174,232 |
| 2006-12-01 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2006-11-01 | ALTU | Option Ex | 9,750 | 3.92 | 38,220 |
| 2006-11-01 | ALTU | Sale | 9,750 | 16.07 | 156,682 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berkle Sheldon (President and CEO of Altus Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.